Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$105,000.00

Elucidating the role of Bmal1 in regulating circadian secretion of glucagon-like peptide-1 from the intestinal L cell

EF 2016-17

Résumé
Circadian rhythms are biological processes within organisms that follow a pattern of approximately 24 hours. These 24 hour rhythms are regulated by specific genes which are commonly referred to as clock genes. It has been reported that individuals with disrupted circadian rhythms, such as those conducting shift-work are at an increased risk of developing type 2 diabetes and obesity. Furthermore, previous work from the Brubaker laboratory has shown that an important anti-diabetic hormone, glucagon-like peptide-1 (GLP-1), has a circadian rhythm of release into the bloodstream, and this is disrupted in cases of where the natural circadian rhythms are altered. The specific goal of my project is to investigate the mechanism by which clock genes regulate release of GLP-1, in the hopes of identifying novel therapeutic strategies for individuals with blood glucose disorders due to circadian disruption. More specifically, I will investigate the clock gene Bmal1 as a potential positive regulator of rhythmic GLP-1 release using both cell and mouse models. Furthermore, previous work I have conducted identified an alteration of a protein, secretagogin (Scgn), that is directly involved in release of GLP-1 into the bloodstream. Using my cell model, I will decrease expression of Bmal1 and Scgn and measure the effects on the pattern of GLP-1 release. I will then perform studies on my mouse models where Bmal1 and Scgn have been genetically eliminated by measuring GLP-1 release into the bloodstream at different time points throughout the day. Together the cell and animal studies will provide novel insight into the pattern of GLP-1 release which would open new avenues for developing treatments for many patients with blood glucose abnormalities due to disrupted circadian rhythms.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
365471
Name
Martchenko Alexandre
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Elucidating the role of Bmal1 in regulating circadian secretion of glucagon-like peptide-1 from the intestinal L cell
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Circadian Rhythms; Diabetes And Metabolic Syndrome; Glucagon-Like Peptide-1; Rhythmic Secretion
Abstract
Circadian rhythms are biological processes within organisms that follow a pattern of approximately 24 hours. These 24 hour rhythms are regulated by specific genes which are commonly referred to as clock genes. It has been reported that individuals with disrupted circadian rhythms, such as those conducting shift-work are at an increased risk of developing type 2 diabetes and obesity. Furthermore, previous work from the Brubaker laboratory has shown that an important anti-diabetic hormone, glucagon-like peptide-1 (GLP-1), has a circadian rhythm of release into the bloodstream, and this is disrupted in cases of where the natural circadian rhythms are altered. The specific goal of my project is to investigate the mechanism by which clock genes regulate release of GLP-1, in the hopes of identifying novel therapeutic strategies for individuals with blood glucose disorders due to circadian disruption. More specifically, I will investigate the clock gene Bmal1 as a potential positive regulator of rhythmic GLP-1 release using both cell and mouse models. Furthermore, previous work I have conducted identified an alteration of a protein, secretagogin (Scgn), that is directly involved in release of GLP-1 into the bloodstream. Using my cell model, I will decrease expression of Bmal1 and Scgn and measure the effects on the pattern of GLP-1 release. I will then perform studies on my mouse models where Bmal1 and Scgn have been genetically eliminated by measuring GLP-1 release into the bloodstream at different time points throughout the day. Together the cell and animal studies will provide novel insight into the pattern of GLP-1 release which would open new avenues for developing treatments for many patients with blood glucose abnormalities due to disrupted circadian rhythms.
Competitiondate
201610
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Martchenko, Alexandre
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~